Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
PGNY Transcript
Progyny, Inc. (PGNY) Q4 2025 Earnings Call Transcript
Positive2-26
The earnings call shows strong financial performance with a 20% revenue growth excluding a large client, a double-digit increase in EBITDA, and a significant rise in operating cash flow. Share repurchases further indicate confidence. Despite some margin compression and conservative guidance, the company is expanding its product offerings and has a positive outlook on membership and revenue growth. The Q&A section reveals some uncertainties, but overall sentiment remains positive. Given the company's market cap, a 2% to 8% stock price increase is likely over the next two weeks.
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-13
Progyny, Inc. (PGNY) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call shows a positive sentiment with strong financial health, no debt, and expanding profit margins. The Q&A section reveals management's confidence despite minor headwinds, with no significant risks identified. Guidance is stable, and there is potential for upselling new products. The market cap suggests moderate volatility, aligning with a positive stock price reaction.
Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call highlights strong financial performance with increased gross margins, net income, and record ART cycles. Despite slightly lower EBITDA margins, revenue growth in fertility and pharmacy segments is robust. The Q&A reveals positive engagement, pipeline recovery, and no adverse impact from industry layoffs. Guidance remains optimistic, and demand for services is rising across company sizes. The market cap suggests moderate volatility, aligning with a positive stock price movement expectation of 2% to 8% in the short term.
PGNY Slides
PGNY Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
